Zacks: Brokerages Set $5.50 Price Target for Harvard Bioscience, Inc.


Shares of Harvard Bioscience, Inc. have been given an average broker rating score of 1.00 from the two analysts that provide coverage for the company, Zacks Investment Research reports. Two equities research analysts have rated the stock with a strong buy rating.



from Biotech News